1. Home
  2. Labeler Index
  3. Nutritional Specialties, Inc.
  4. NDC Product Code: 83027-0018 Female Liquescence

NDC 83027-0018 Female Liquescence

Dioscorea Villosa,Glycyrrhiza Glabra,Hamamelis Virginiana,Rubus Idaeus,Viburnum - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 83027-0018?
  4. Female Liquescence Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. Pharmacologic Classes

Product Information

Get all the details for National Drug Code (NDC) 83027-0018 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
83027-0018
Proprietary Name:
Female Liquescence
Non-Proprietary Name: [1]
Dioscorea Villosa, Glycyrrhiza Glabra, Hamamelis Virginiana, Rubus Idaeus, Viburnum Opulus, Caulophyllum Thalictroides, Oophorinum (suis), Uterus (suis), Human Growth Hormone (hgh), Ignatia Amara
Substance Name: [2]
Caulophyllum Thalictroides Root; Dioscorea Villosa Tuber; Glycyrrhiza Glabra; Hamamelis Virginiana Root Bark/stem Bark; Rubus Idaeus Leaf; Somatropin; Strychnos Ignatii Seed; Sus Scrofa Ovary; Sus Scrofa Uterus; Viburnum Opulus Bark
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route(s): [4]
Oral - Administration to or by way of the mouth.
Labeler Name: [5]
Nutritional Specialties, Inc.
Labeler Code:
83027
Product Label ID:
fc8b2c91-d4b3-410e-b952-b1f53e0030af
Marketing Category: [8]
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date: [9]
02-22-2023
End Marketing Date: [10]
07-31-2028
Exclude Flag: [12]
N
Code Navigator:

Code Structure Chart

Product Details

What is NDC 83027-0018?

The NDC code 83027-0018 is assigned by the FDA to the product Female Liquescence which is a human over the counter drug product labeled by Nutritional Specialties, Inc.. The generic name of Female Liquescence is dioscorea villosa, glycyrrhiza glabra, hamamelis virginiana, rubus idaeus, viburnum opulus, caulophyllum thalictroides, oophorinum (suis), uterus (suis), human growth hormone (hgh), ignatia amara. The product's dosage form is liquid and is administered via oral form. The product is distributed in a single package with assigned NDC code 83027-0018-1 120 ml in 1 bottle, glass . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Female Liquescence?

Adults 1 to 2 teaspoons one to two times daily. Children under twelve one half adult dosage. Consult a physician for use in children under 12 years of age.

What are Female Liquescence Active Ingredients?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Which are Female Liquescence UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Female Liquescence Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

Which are the Pharmacologic Classes for Female Liquescence?

* Please review the disclaimer below.

Product Footnotes

[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".